Atai Life Sciences Profit Margin 2020-2024 | ATAI
Current and historical gross margin, operating margin and net profit margin for Atai Life Sciences (ATAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atai Life Sciences net profit margin as of June 30, 2024 is -12810.51%.
| Atai Life Sciences Annual Profit Margins |
|---|
| Atai Life Sciences Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.196B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.044B | 12.73 |
| Quest Diagnostics (DGX) | United States | $17.232B | 17.67 |
| DaVita (DVA) | United States | $13.682B | 16.83 |
| Encompass Health (EHC) | United States | $9.661B | 23.76 |
| Chemed (CHE) | United States | $9.016B | 27.72 |
| Elanco Animal Health (ELAN) | United States | $7.079B | 15.91 |
| Option Care Health (OPCH) | United States | $5.374B | 26.40 |
| RadNet (RDNT) | United States | $5.127B | 121.63 |
| Amedisys (AMED) | United States | $3.164B | 22.63 |
| Astrana Health (ASTH) | United States | $2.775B | 39.26 |
| LifeStance Health (LFST) | United States | $2.655B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.370B | 28.78 |
| U.S Physical Therapy (USPH) | United States | $1.272B | 34.44 |
| Pennant (PNTG) | United States | $1.039B | 49.84 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.999B | 0.00 |
| Daxor (DXR) | United States | $0.043B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.027B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |